4D Molecular Therapeutics... (FDMT)

NASDAQ: FDMT · Real-Time Price · USD

3.77

0.33 (9.59%)

At close: May 02, 2025, 3:59 PM

3.75

-0.66%

After-hours: May 02, 2025, 05:57 PM EDT

4D Molecular Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-160.87M	-100.84M	-107.49M	-71.32M	-56.69M	-49.31M	-9.55M	-11.22M
Depreciation & Amortization	6.71M	5.75M	3.88M	3.02M	1.44M	1M	697K	626K
Stock-Based Compensation	26.12M	19.66M	17.12M	13.8M	4.98M	3.54M	1.38M	256K
Other Working Capital	-334K	-266K	255K	-14.72M	345K	-3.35M	-8.59M	19.03M
Other Non-Cash Items	-7.08M	-999K	1.14M	898K	48K	5.14M	2K	39K
Deferred Income Tax	n/a	n/a	n/a	n/a	20K	2.65M	n/a	n/a
Change in Working Capital	537K	630K	-1.34M	-15.53M	-711K	259K	-8.78M	18.54M
Operating Cash Flow	-134.59M	-75.79M	-86.69M	-69.13M	-50.91M	-36.71M	-16.25M	8.24M
Capital Expenditures	n/a	-2.77M	-11.54M	-9.11M	-1M	-3.2M	-414K	-573K
Cash Acquisitions	n/a	n/a	11.54M	9.11M	n/a	n/a	n/a	24K
Purchase of Investments	-467.65M	-54.8M	-153.31M	-168.57M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	169M	n/a	147.8M	5M	n/a	n/a	n/a	8.22M
Other Investing Acitivies	-3.79M	173.29M	-11.54M	-9.11M	-1M	n/a	n/a	24K
Investing Cash Flow	-302.44M	115.72M	-17.05M	-172.68M	-1M	-3.2M	-414K	7.67M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-2.27M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	5.84M	8.49M	3.08M	3.79M	857K	n/a	84.58M	n/a
Financial Cash Flow	337.25M	156.83M	3.08M	118.09M	278.98M	-2.19M	84.58M	16K
Net Cash Flow	-99.77M	196.76M	-100.65M	-123.72M	227.07M	-42.11M	67.91M	15.93M
Free Cash Flow	-138.37M	-78.56M	-98.22M	-78.24M	-51.91M	-39.91M	-16.67M	7.66M